rufinamide
rufinamide is listed in the FDA National Drug Code directory with 11 NDC codes, marketed under brand names including rufinamide, RUFINAMIDE, Banzel. Available dosage forms: tablet, film coated, suspension, powder.
Drug Details
- Generic Name
- rufinamide
- Brand Names
- rufinamide, RUFINAMIDE, Banzel, Rufinamide
- Application Number
- ANDA205075
- Sponsor
- Glenmark Pharmaceuticals Inc., USA
- NDC Codes
- 11
- Dosage Forms
- TABLET, FILM COATED, SUSPENSION, POWDER
- Routes
- ORAL
- Active Ingredients
- RUFINAMIDE
Indications and Usage
1 INDICATIONS AND USAGE Rufinamide oral suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults. Rufinamide oral suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults ( 1 )